Actively Recruiting
New Diagnostic Approaches to Identify Ferroptosis or Pyroptosis in Critically Ill ICU Patients Including Those With Sepsis, Trauma, or Neurological Catastrophes
Led by University Hospital, Antwerp · Updated on 2025-04-15
600
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating critically ill patients admitted to the intensive care unit ICU with conditions such as sepsis, trauma, hemorrhagic shock, or neurological catastrophes. The study aims to determine the role of ferroptosis, a type of iron-related cell death, by measuring biomarkers in blood and other biological fluids. Understanding ferroptosis could help identify the underlying causes of organ failure during ICU stays and potentially guide future therapies. Participants in this study will undergo blood sampling and collection of urine, bronchoalveolar lavage fluid BALF, and cerebrospinal fluid CSF during the first three days of ICU admission. Blood samples will be taken daily for the first three days, with 2 ml of plasma collected each day. These samples will help evaluate the biochemical pathways involved in organ failure among critically ill patients. During the study, researchers will monitor the number of patients who survive after 28 days, track daily changes in norepinephrine concentration during the ICU stay, and assess changes in SOFA scores up to 14 days after enrollment. Participants must have an arterial line for blood sampling and are expected to stay in the ICU for more than 48 hours. The study will also include safety and outcome assessments during the ICU stay and up to 28 days.
CONDITIONS
Brief Title
Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies
Research Team
T
Tom Stroobants, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here